Vaccines & Meds Safety & Utilisation Research

Vaccines and Meds Safety | [email protected] | [email protected]

[Dan Kajungu, PhD @dkaj04]

Thank you @dfkm1970 @Zahranamuli @MAGEZIKIRIINJJU @nbstv @ntvuganda @ubctvuganda

[Dan Kajungu, PhD @dkaj04]

Minor side effects are a normal sign that the immune system is mounting a protective response following vaccination, although they aren’t universal. @VxMedSS
@NambasaVictoria @EDCTP @dkaj04 @MinofHealthUG https://t.co/Q0ovtdSsPn

[EDCTP @EDCTP]

Join the 10th EDCTP Forum "Equity in research for health"
⭐️When: 17-21 October 2021
⭐️Hybrid
⭐️Registration: free
⭐️More info: https://t.co/WgqlaV0uif

@WHOAFRO @AfricaCDC @dsw_intl @EMA_News @eu

[EU Medicines Agency @EMA_News]

#COVID19vaccines: where are we now?
Rolling reviews in progress, no new applications submitted, authorisations completed

[Vaccines & Meds Safety & Utilisation Research @VxMedSS]

AstraZeneca COVID Vaccine: Clotting Disorder Mechanism Revealed? https://t.co/DGBh3yNXIP via @medscape

[PV Papers @PVpapers]

Progress in Immunization Safety Monitoring — Worldwide, 2010–2019

https://t.co/cahNQYsAeU

[Vaccines & Meds Safety & Utilisation Research @VxMedSS]

@dkaj04

[Dr. Tom Frieden @DrTomFrieden]

Side effects after vaccination are a normal sign that your body is building protection against Covid. You may experience more intense side effects after your second shot, but they'll go away in a day or two – much faster than many people recover from Covid.

[Ministry of Health- Uganda @MinofHealthUG]

Dear health worker,
You are a role model in society. Get vaccinated against COVID-19 today and encourage your colleagues to get vaccinated too. #COVIDVaccinationUG

[Dan Kajungu, PhD @dkaj04]

Gestational age data completeness, quality and validity in population-based surveys. @ResearchGate: https://t.co/0Ak6dkUrey

[Vaccines & Meds Safety & Utilisation Research @VxMedSS]

Top 3 COVID-19 vaccine questions – Second vaccine dose, vaccine safety and consent forms https://t.co/3TowmRHxUV

[Dan Kajungu, PhD @dkaj04]

If the perception takes hold that rich countries are dumping second-rate shots on poorer nations, those suspicions could harden, slowing the worldwide rollout of desperately needed doses.
Western Warnings Tarnish Covid Vaccines the World Badly Needs https://t.co/0WxEpMUCsg

[Vaccines & Meds Safety & Utilisation Research @VxMedSS]

@CEPIvaccines aims to work with low-income and middleincome countries to develop the infrastructure and expertise to undertake the epidemiological and clinical studies needed to advance vaccine development. https://t.co/Zuej28uRlO @dkaj04

[EU Medicines Agency @EMA_News]

#COVID19vaccines: where are we now?
Rolling reviews in progress, submitted applications, authorisations completed 👇

[Vaccines & Meds Safety & Utilisation Research @VxMedSS]

#VaccinesWork

[John Nkengasong @JNkengasong]

Vaccines + Vaccination = Saved Lives.
Take the Vaccine today. Don't put yourself at risk of infection.
#VaccinationSavesLives #VaccinesForAfrica. #FactNotFear.

[Vaccines & Meds Safety & Utilisation Research @VxMedSS]

Why is it so hard to investigate the rare side effects of COVID vaccines? https://t.co/1shQNwy8PJ @dkaj04 @NambasaVictoria

[WHO African Region @WHOAFRO]

Join us for tomorrow's press conference on #COVID19 vaccine rollout in #Africa. Dr @MoetiTshidi will be joined by Dr Abdelhakim Yahyane, #Morocco Ministry of Health, & @MohamedFall, @UNICEFAfrica.

🕚11am (GMT +1)
🗓️8th April
⏯️https://t.co/tanfZ0mZI3

[Vaccines & Meds Safety & Utilisation Research @VxMedSS]

Tackling Misconceptions That Result in COVID-19 Vaccine Hesitancy https://t.co/uh6SWMmKyU via @Pharmacy_Times

[Vaccines & Meds Safety & Utilisation Research @VxMedSS]

WHO, EMA reaffirm safety of AstraZeneca vaccine following EU suspensions https://t.co/tmC4nbSGai

[Vaccines & Meds Safety & Utilisation Research @VxMedSS]

UgVacSafe Solution enables vaccine recipients to report any adverse event following immunisation (AEFI) following COVID-19 vaccine to supplement the passive surveillance system. https://t.co/YesFjROzdJ @dkaj04 @GyezCollins @PVpapers

[EU Medicines Agency @EMA_News]

‼️ A press briefing on EMA’s safety committee (PRAC) conclusion on the review of #COVID19vaccine AstraZeneca and blood clots is planned at 4:00PM CET today.

Follow live: https://t.co/BpYBxkk9E6